Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: Effect of verapamil and trandolapril

Hypertension

Volumn 27, Issue 1, 1996, Pages 25-31

  Takase, Hiroyuki ^a   Morcau, Pierre ^a   Küng, Christoph F ^a   Nava, Eduardo ^a   Lüscher, Thomas F ^a,b  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

antihypertensive therapy; endothelium derived relaxing factors; L NAME; nitric oxide

Indexed keywords

ACETYLCHOLINE; ARGININE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NORADRENALIN BITARTRATE; PLACEBO; TRANDOLAPRIL; TRANDOLAPRILAT; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM INJURY; ENZYME ACTIVITY; HEART RATE; MALE; MESENTERIC ARTERY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENAL ARTERY; SYSTOLIC BLOOD PRESSURE;

EID: 0030039486     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.1.25     Document Type: Article

References (42)

1. Moncada S. The L-arginine:nitric oxide pathway. Acta Physiol Scand. 1992;145:201-227.
2. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla: CRC Press; 1990:1-215.
3. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial, nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
4. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 1989;86:3375-3378.
5. Schmidt HHHW, Zerinkow B, Baeblich S, Böhme E. Basal and stimulated formation and release of L-arginine-derived nitrogen oxides from cultured endothelial cells. J Pharmacol Exp Ther. 1990;254:591-597.
6. Buga GM, Gold ME, Fukuto JM, Ignarro L. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension. 1991;17:187-193.
7. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
8. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
9. G-nitro-L-arginine methyl ester in conscious. Long Evans rats. Br J Pharmacol. 1990;101:625-631.
10. Arnal J-F, Warin L, Michel J-B. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest. 1992;90:647-652.
11. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
12. Manning RDJ, Hu L, Mizelle L, Montani J-P, Norton MW. Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension. 1993;22:40-48.
13. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zats R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
14. Lüscher TF, Vanhoutte PM. Antihypertensive therapy normalizes endothelium-dependent relaxations in salt-induced hypertension of the rat. Hypertension. 1987;9(suppl III):III-193-III-197.
15. Yang S-T, Mayhan WG, Faraci FM, Heistad DD. Endothelium-dependent responses of cerebral blood vessels during chronic hypertension. Hypertension. 1991;17:612-618.
16. Diederich D, Yang Z, Bühler FR, Lüscher TF. Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve the cyclooxygenase pathway. Am J Physiol. 1990;258: H445-H451.
17. Dohi Y, Thiel MA, Bühler FR, Lüscher TF. Activation of endothelial L-arginine pathway in resistance arteries: effect of age and hypertension. Hypertension. 1990;15:170-179.
18. Linder L., Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
19. Panza JA, Quyyumi AA, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
20. Treasure CB, Manoukian SV, Klein JL, Vita JA, Nabel EG, Renwick GH, Selwyn AP, Alexander RW, Ganz P. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 1992;71:776-781.
21. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
22. Nava E, Moreau P, Lüscher TF. The nitric oxide pathway in mesenteric resistance vessels from genetically hypertensive rats. Eur J Clin Invest. 1995;25(suppl 2):A3. Abstract.
23. Tschudi MR, Criscione L, Novosel D, Pfeiffer K, Lüscher TF. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation. 1994;89:2212-2218.
24. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532-540.
25. 2+-antagonists. J Cardiovasc Pharmacol. 1988;12(suppl 6):21-28.
26. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension. 1993;21:660-666.
27. Nara Y, Ikeda K, Yamori Y. Preventive effect of manidipine on severe hypertension and proteinuria induced by the inhibition of endothelial-derived relaxing factor formation in stroke-prone spontaneously hypertensive rats. Blood Pressure. 1992;1(suppl 3):85-86.
28. Jover B, Herizi A, Ventre F, Dupont M, Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension. 1993;21:944-948.
29. Nava E, Noll G, Lüscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation. 1995;91:2310-2313.
30. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994;91:5212-5216.
31. Wallenstein S, Zucker CL, Fleiss J. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-4.
32. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
33. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21:1145-1151.
34. Wiemer G, Schölkens BA, Becker RHA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991;18:558-563.
35. Mombouli J-V, Nephtali M, Vanhoutte PM. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension. 1991;18(suppl II):II-22-II-29.
36. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
37. Cachofeiro V, Sakakibara T, Nasjletti A. Kinin, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension. 1992;19:138-145.
38. Mombouli J-V, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 1992;71:137-144.
39. Singer HA, Peach MJ. Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension. 1982;4(suppl II):II-19-II-25.
40. Novosel D, Lang MG, Noll G, Lüscher TF. Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone rat: effects of therapy with verapamil and trandolapril alone and in combination. J Cardiovasc Pharmacol. 1994;24:979-985.
41. Illiano S, Mombouli JV, Nagao T, Vanhoutte PM. Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin. J Cardiovasc Pharmacol. 1994:23(suppl 4):S6-S10.
42. Creager MA, Roddy M-A. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24:499-505.